Table of contents
Volume 94, Issue 7
Published online 4 April 2006 (941-1086)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Book Review
Minireview
Towards third generation matrix metalloproteinase inhibitors for cancer therapy FREE
C M Overall and O Kleifeld
Br J Cancer 94: 941-946; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603043
Clinical Studies
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial FREE
P M Wilkinson, M Antonopoulos, M Lahousen, M Lind and P Kosmidis for the EPO-INT-45 Study Group
Br J Cancer 94: 947-954; advance online publication, March 28, 2006; doi:10.1038/sj.bjc.6603004
Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival FREE
M Pitchers and C Martin
Br J Cancer 94: 955-958; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603044
A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer FREE
Y H Park, B-S Kim, B-Y Ryoo and S H Yang
Br J Cancer 94: 959-963; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603046
A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer FREE
R Sharma, L Rivory, P Beale, S Ong, L Horvath and S J Clarke
Br J Cancer 94: 964-968; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603049
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer FREE
J Feliu, A Salud, P Escudero, L Lopez-Gómez, M Bolaños, A Galán, J-M Vicent, A Yubero, F Losa, J De Castro, M Á de Mon, E Casado and M González-Barón on behalf of the Oncopaz Cooperative Group and Associated Hospitals
Br J Cancer 94: 969-975; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603047
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study FREE
G Klautke, U Küchenmeister, T Foitzik, K Ludwig, F Prall, E Klar and R Fietkau
Br J Cancer 94: 976-981; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603053
Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies FREE
P C Simmonds, J N Primrose, J L Colquitt, O J Garden, G J Poston and M Rees
Br J Cancer 94: 982-999; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603033
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy FREE
V Martinez, E Caumes, L Gambotti, H Ittah, J-P Morini, J Deleuze, I Gorin, C Katlama, F Bricaire and N Dupin
Br J Cancer 94: 1000-1006; advance online publication, March 28, 2006; doi:10.1038/sj.bjc.6603056
Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield FREE
T Seshadri, D Gook, S Lade, A Spencer, A Grigg, K Tiedemann, J McKendrick, P Mitchell, C Stern and J F Seymour
Br J Cancer 94: 1007-1010; advance online publication, March 28, 2006; doi:10.1038/sj.bjc.6603050
Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy FREE
J Vardy, K S Chiew, J Galica, G R Pond and I F Tannock
Br J Cancer 94: 1011-1015; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603048
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study FREE
C Bengala, C Zamagni, P Pedrazzoli, P Matteucci, A Ballestrero, G Da Prada, M Martino, G Rosti, M Danova, M Bregni, G Jovic, V Guarneri, M Maur and P F Conte on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) group
Br J Cancer 94: 1016-1020; advance online publication, March 28, 2006; doi:10.1038/sj.bjc.6603060
Translational Therapeutics
Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations FREE
M Bramley, R B Clarke, A Howell, D G R Evans, T Armer, A D Baildam and E Anderson
Br J Cancer 94: 1021-1028; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603042
CCL19 reduces tumour burden in a model of advanced lung cancer FREE
S Hillinger, S-C Yang, R K Batra, R M Strieter, W Weder, S M Dubinett and S Sharma
Br J Cancer 94: 1029-1034; doi:10.1038/sj.bjc.6603061
Molecular Diagnostics
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer FREE
F J G M Kubben, C F M Sier, W van Duijn, G Griffioen, R Hanemaaijer, C J H van de Velde, J H J M van Krieken, C B H W Lamers and H W Verspaget
Br J Cancer 94: 1035-1040; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603041
Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma FREE
D Muller, R Millon, S Théobald, T Hussenet, B Wasylyk, S du Manoir and J Abecassis
Br J Cancer 94: 1041-1044; doi:10.1038/sj.bjc.6603036
Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix FREE
F Erlandsson, H-S Martinsson-Ahlzén, K-L Wallin, A-C Hellström, S Andersson and A Zetterberg
Br J Cancer 94: 1045-1050; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603038
Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole FREE
W R Miller, S White, J M Dixon, J Murray, L Renshaw and T J Anderson
Br J Cancer 94: 1051-1056; advance online publication, March 14, 2006; doi:10.1038/sj.bjc.6603001
Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients FREE
H E Innes, D Liu, R Barraclough, M P A Davies, P A O'Neill, A Platt-Higgins, S de Silva Rudland, D R Sibson and P S Rudland
Br J Cancer 94: 1057-1065; doi:10.1038/sj.bjc.6603065
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome FREE
T Bachelot, D Ratel, C Menetrier-Caux, D Wion, J-Y Blay and F Berger
Br J Cancer 94: 1066-1070; advance online publication, March 21, 2006; doi:10.1038/sj.bjc.6603037
Epidemiology
Use of antidepressant medications in relation to the incidence of breast cancer FREE
D Fulton-Kehoe, M A Rossing, C Rutter, M T Mandelson and N S Weiss
Br J Cancer 94: 1071-1078; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603017
Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001–2003 FREE
S H Wild, C M Fischbacher, A Brock, C Griffiths and R Bhopal
Br J Cancer 94: 1079-1085; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603031
Book Review
Cancer therapy – molecular targets in tumour–host interactions FREE
P Kurschat and C Mauch
Br J Cancer 94: 1086; doi:10.1038/sj.bjc.6603045
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
